Talk:Multidisciplinary Association for Psychedelic Studies

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Psychoactive and Recreational Drugs (defunct)

This article is within the scope of WikiProject Psychoactive and Recreational Drugs, a project which is currently considered to be defunct.Psychoactive and Recreational DrugsWikipedia:WikiProject Psychoactive and Recreational DrugsTemplate:WikiProject Psychoactive and Recreational DrugsPsychoactive and Recreational Drugs articles

Organizations Low‑importance

	This article is within the scope of WikiProject Organizations, a collaborative effort to improve the coverage of Organizations on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.OrganizationsWikipedia:WikiProject OrganizationsTemplate:WikiProject Organizationsorganization articles
Low	This article has been rated as Low-importance on the project's importance scale.

Medicine: Society Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Society and Medicine task force (assessed as Low-importance).

California Low‑importance

	California portal This article is within the scope of WikiProject California, a collaborative effort to improve the coverage of the U.S. state of California on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CaliforniaWikipedia:WikiProject CaliforniaTemplate:WikiProject CaliforniaCalifornia articles
Low	This article has been rated as Low-importance on the project's importance scale.

completely new introductory section[edit]

In adding this section, I've removed a couple of quotes about MAPS' relationship with NIDA and the DEA. I'm planning on putting these back in when I add a more complete section on MAPS' DEA lawsuit, and all of the research mentioned is mentioned again with [citation needed] marks in the "Achievements" section. I'll be going through and adding those citations soon as I develop the page around the new contents list mentioned below.

Kymerikal (talk) 16:14, 20 February 2010 (UTC)[reply]

proposed new contents list for new MAPS wiki page[edit]

I'm working on getting this page fully rewritten. It could use a lot more detail, clearer organization, and of course sourcing, about MAPS-sponsored research studies, for example. Here's the contents list that I'm working with as I compose a draft. I was going to just throw it all up there as I got them done, but since it looks like there's a couple of people watching this article I thought it might be more productive to ask for comments?

1 MAPS 1.1 Overview 1.2 Mission statement

2 Organization 2.1 Non-profit status 2.2 Membership structure 2.3 Board of directors

3 History 3.1 Founding 3.2 1986-1996 3.3 1997-2004 3.4 2005-present

4 Research 4.1 MDMA 4.2 Medical marijuana 4.3 Psilocybin 4.4 LSD 4.5 Ibogaine

5 Legal 5.1 Medical marijuana DEA lawsuit

6 Education 6.1 Conferences 6.2 Seminars 6.3 Community events

7 Media and publishing

8 See also 9 References 10 External links

Kymerikal (talk) 16:23, 18 February 2010 (UTC)[reply]

relationship with NIDA[edit]

I've removed part of a sentence regarding MAPS' relationship with the NIDA. The phrase was attributed to MAPS founder Rick Doblin regarding the NIDA and read:

"and "we don't want their weed" anyways becasue it is "schwag" a street term for low grade cheap pot."

This was based on an actual quote by Doblin in which he said "we don't want their (the NIDA's) weed." Doblin was comparing the quality of NIDA medical marijuana to that made by Paget, GW Pharmaceuticals for research purposes. The quote was taken out of context such that it might imply that Doblin was discussing NIDA marijuana for personal use. Further, Doblin did not use the term "schwag" - that term was used by the author of the Mother Jones article. Jts3k 22:03, 23 April 2007 (UTC)[reply]

Nevertheless, it's a matter of historical record that Government cannabis is basically worthless. Viriditas (talk) 00:18, 15 January 2009 (UTC)[reply]

Is the neutrality tag still needed? Anyone? Sud Ram (talk) 08:39, 17 February 2010 (UTC)[reply]

Multiple stubs[edit]

Grutness tells me that an article should be in no more than two stub categories, so i'm going to eliminate the "organization" stub as it seems the least useful of the three. if there are objections drop me a note and we can work something else out. --Heah (talk) 19:06, 21 May 2005 (UTC)[reply]

Medical Marijuana Monopoly[edit]

This section requires an update, as it references 2006 as its most recent date. Further, most content appears to be identical to information on the NIDA page, where it has the citations that are missing from the MAPS page. — Preceding unsigned comment added by Gnosotros (talk • contribs) 22:58, 14 April 2011 (UTC)[reply]

File:MAPS logo.jpg Nominated for speedy Deletion[edit]

An image used in this article, File:MAPS logo.jpg, has been nominated for speedy deletion for the following reason: Wikipedia files with no non-free use rationale as of 24 November 2011

What should I do?

Don't panic; you should have time to contest the deletion (although please review deletion guidelines before doing so). The best way to contest this form of deletion is by posting on the image talk page.

If the image is non-free then you may need to provide a fair use rationale
If the image isn't freely licensed and there is no fair use rationale, then it cannot be uploaded or used.
If the image has already been deleted you may want to try Deletion Review

This notification is provided by a Bot --CommonsNotificationBot (talk) 20:08, 24 November 2011 (UTC)[reply]

Vastly out of date, please update, move things to history, and focus on current activities[edit]

I am too close to the subject to edit the page, but I can see that the bulk of the article seems to have been written in about 2012 and never updated since. The organization has changed radically since then, focusing on MDMA research toward PTSD and not continuing most other substance research. Finances are dramatically different, and it now owns a roughly 100-person subsidiary that will be commercializing MDMA after FDA approval, expected in 2024. It's fun to see a capsule view of the org from a decade ago, but Wikipedia readers deserve better. There should be no trouble finding modern, independent coverage of MAPS to cite, as their issue is heading rapidly toward the mainstream. --Gnuish (talk) 08:15, 22 July 2023 (UTC)[reply]

Agreed. I just put up a notice for this. I've been working on revamping Bluelight's page and will start with MAPS afterwards. BromoPhenethylamine (talk) 05:10, 5 February 2024 (UTC)[reply]